Tag.bio and SimpleTherapy Partner to Bring Transparency in Precision Medicine

Tag.bio, the leading provider of data mesh for life sciences and precision medicine, announced a new partnership with SimpleTherapy, an innovative provider of integrated, omnichannel care for Musculoskeletal (MSK) and behavioral health services. Together, the companies aim to improve the accuracy of patient diagnoses, the effectiveness of treatments, and reduction of overall healthcare costs by combining their expertise in data analytics and personalized healthcare.

AiThority Interview Insights: AiThority Interview with at Brian Sathianathan, Co-Founder and CTO at Iterate.ai

“By leveraging our powerful data mesh platform for analytics, we can provide SimpleTherapy and its customers with a more comprehensive understanding of patient data, enabling them to deliver more personalized and cost effective treatments.”

MSK issues significantly impact employers and health plans due to increased healthcare costs and reduced employee productivity. For members, these conditions can impair quality of life, leading to chronic pain and mobility limitations. Effectively addressing MSK disorders is crucial to control costs, improve health outcomes, and enhance member well-being.

“Precision medicine is revolutionizing the healthcare industry, and our partnership with SimpleTherapy represents a significant step forward in this field,” said Tom Covington, CEO of Tag.bio. “By leveraging our powerful data mesh platform for analytics, we can provide SimpleTherapy and its customers with a more comprehensive understanding of patient data, enabling them to deliver more personalized and cost effective treatments.”

Read More about AiThority Interview: AiThority Interview with Thomas Kriebernegg, Managing Director & Co-Founder at App Radar

Arpit Khemka, Co-Founder & CEO of SimpleTherapy, expressed enthusiasm about the partnership, saying, “Our collaboration with Tag.bio represents a significant milestone for SimpleTherapy as we enhance our platform’s capabilities. This partnership reaffirms our commitment to providing genuine value, emphasizing transparency, long-term results, and unparalleled quality. We believe this alliance distinguishes us in the industry and ensures optimal outcomes for our clients and their members.”

Khemka added, “By integrating Tag.bio’s data mesh solution, we can empower healthcare providers to personalize physical therapy treatment plans, and enable employers and health plans to accurately evaluate and predict the impact on cost and outcomes. This ultimately leads to improved patient outcomes and reduced healthcare costs.”

 Latest AiThority Interview Insights : AiThority Interview with Joshua Wilson, Commercial Director, JAPAC at Crimtan

 [To share your insights with us, please write to sghosh@martechseries.com]